Search
Displaying 5321–5330 of 5594 results.
The Xuejun Jiang Lab
The Alan Hanash Lab
The Ricardo Otazo Lab
The Karuna Ganesh Lab
News
Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
The Daniel Bachovchin Lab
The Omar Abdel-Wahab Lab
The Lorenz Studer Lab
News
Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.